BioCryst Pharmaceuticals
BCRX
#4788
Rank
NZ$2.64 B
Marketcap
$12.78
Share price
2.60%
Change (1 day)
51.70%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$1.38 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total debt is NZ$1.38 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BioCryst Pharmaceuticals - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$1.30 B11.73%
2022-12-31NZ$1.16 B34.46%
2021-12-31NZ$0.86 B124.21%
2020-12-31NZ$0.38 B208.18%
2019-12-31NZ$0.12 B36.38%
2018-12-31NZ$92.16 M19.62%
2017-12-31NZ$77.05 M-0.65%
2016-12-31NZ$77.55 M75.89%
2015-12-31NZ$44.09 M15.16%
2014-12-31NZ$38.28 M4.88%
2013-12-31NZ$36.5 M0.11%
2012-12-31NZ$36.46 M-5.13%
2011-12-31NZ$38.43 M
2000-12-31NZ$0.02 M
1997-12-31NZ$0.17 M-59.42%
1996-12-31NZ$0.42 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$1.26 B-8.19%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.38 B 72.72%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.55 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.39 B-71.17%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$39.83 B 2,785.79%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.26 M-99.62%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$36.66 B 2,556.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$1.47 B 6.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$20.69 M-98.50%๐Ÿ‡บ๐Ÿ‡ธ USA